MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Unveil the role of genetic testing in diagnosing and managing Combined Oxidative Phosphorylation Defect Type 17, offering clarity in treatment and family planning.
Explore the impact of genetic testing in diagnosing COXPD19, a rare mitochondrial disorder. Learn how it aids in early detection, personalized treatment, and research.
Explore how genetic testing revolutionizes CDCBM3 diagnosis and treatment, aiding early detection, personalized care, and informed family planning decisions.
Unravel the complexities of CDCBM4 with genetic testing. Discover how early diagnosis, personalized care, and informed family planning are transforming lives.
Explore how genetic testing aids in diagnosing congenital muscular dystrophy with intellectual disability and severe epilepsy for tailored treatments and family planning.
Navigate CMS8's complexities with genetic testing, offering precision diagnosis, personalized treatments, and insights into genetic diversity for better outcomes.
Explore how genetic testing identifies mutations in CSBS, leading to personalized treatments, improved patient outcomes, and informed family planning options.
Gain insights on Congenital Stationary Night Blindness 1F, its genetic causes, and how testing guides diagnosis, treatment, and future research for rare eye disorders.